Background/Objective: Leukocyte cell-derived chemotaxin-2 (LECT2), a hepatokine, is implicated in non-alcoholic fatty liver disease (NAFLD). The gene discussed is LECT2; the disease is metabolic dysfunction-associated steatotic liver disease.